Académique Documents
Professionnel Documents
Culture Documents
Dr.G.VIJAYA .MD
• What are the goals of pre op evaluation?
• Pre op risk assessment-ASA classification
• History
• General examination
• Assessment of functional capacity of the pt
• Airway assessment
Assessment for mask ventilation
Assessment for laryngoscopy/intubation
• Evaluation of co existing disease
CVS,RS,LIVER ,RENAL DISORDER
HEMATOLOGY,ENDOCRINE,CNS&
MUSCULOSKELETAL DISORDER
GOALS
Pt with mild systemic disease (eg. mild asthma or well controlled HT)
ASA 2 No significant impact on daily activity
Unlikely to have impact on surgery or anesthesia
Significant severe systemic disease that limits normal activity (renal
failure on dialysis or class II CCF)
ASA 3
Significant impact on daily activity /probable impact on surgery or
anesthesia
Severe disease that is constant threat to life or requires intensive therapy
ASA 4 (eg acute MI, respiratory failure)serious limitation of daily activity
(major impact on surgery or anesthesia)
Moribund pt who is equally likely to die in next 24 hrs with or without
ASA 5
surgery
ASA 6 Brain dead organ donor
E – PRE FIXED FOR EMERGENCY TILL ASA 4 (ASA 4 E)
• History And Physical
examination Are The
Most Important
Assessors Of Disease
And Risk
PRESENTING COMPLAINT
• cardiac disease
• respiratory disease
• arthritis
• endocrine disease - diabetes, obesity etc
• Heart burn/reflex disease
FUNCTIONAL CAPACITY
HISTORY OF
• Snoring
• Day time sleepiness
• Hypertension
• Obesity
Step 4-functional
Proceed to surgery
capacity
Good >4 mets
• H/O SMOKING
• RULE OUT BRONCHIAL ASTHMA
• RULE OUT COPD
• EVALUATE FOR RESTRICTIVE LUNG
DISEASE
• RULE OUT PULMONARY HYPERTENSION
PULMONARY DISORDER
EVALUATION
• H/O smoking
• ASA >2 GRADE
• AGE >70 yrs
• COPD
• Neck ,thoracic,upper abdominal surgery,neuro surgery
• >2 hrs procedures
• Albumin <3 gm/dl
• Exercise capacity <1 flight
• BMI>30
HEPATOBILIARY DISORDER
• H/o-hepatitis-alcoholic,viral
• Obstructive /hemolyric jaundice
• Cirrhosis
• Portal hypertension
• Hepatic encephalopathy
• Wilson’s disease
• Hemochomatosis
• Hepato cellular carcinoma/secondaries
• LFT
• USG
• COAGULATION PROFILE
• SERUM PROTEINS
PUGH‘S MODIFICATION OF CHILD
GRADING-chronic liver disease
Clinical & Biochemical POINTS SCORED
variables 1 2 3
Serum albumin (g/L) >35 28-35 <28
Muddy brown
Urinary sediment Hyaline casts
granular casts
CREATININE CLEARENCE
• Duration
• oral hypoglycemic drugs,insulin
• Rule out micro & macro vascular /end organ
damage
• Diabetic nephropathy
• Silent ischemia
• Autonomic neuropathy-orthostatic
hypotension(>20/10mmhg difference)
• Stiff joint syndrome –difficult intubation
• Fasting blood glucose to be <110mg/dl
• FBS,PPBS
• HB A1C(<7% CARRYS LOW RISK)
• URINE ACETONES
• RFT, ELECTOLYTES
• ECG
• ECHO
ENDOCRINE-THYROID
• Hyper /hypo thyroidism
• Rule out pericardial effusion ,myxoedema-
hypothyroidism
• palpitations, tachycardia
• Arrhythmia-hyperthyroidism
• Ask for anti thyroid,betablockers,steroids
• Eltroxin
• Thyroid function test
• Clinically symptoms /signs - should be
improved
• ENT opinion to rule out pre existing vocal
cord palsy
• X ray neck – to rule out tracheal
compression
OTHER ENDOCRINES
• CVA
• Seizure disorder-treatment/drugs
• Multiple sclerosis
• Cerebral aneurysms
• Neuromusculat junctions disorder
• Muscular dystrophies/myopathies-prone for malignant
hyperthermia.neurolept malignant syndrome
• Intracranial tumours-relative C/I to central neuroxial
block
HEMATOLOGY
• Anemia
• Target >10gm/dl for normal pt
• Desire pre op /intra op blood transfusion
• Rule out Jehovah Witnesses
• Malignancy-metastasis /complications
• Transplanted organ –sepsis/steroids
/chemotherapy
• Obesity/OSA
• HIV
• Drug abuse
• H/O pseudo cholinesterase deficiency
• H/O malignant hyperthermia
ASSESSMENT IN PEDIATRICS
• Prosthetic valves
• Prev IE
• CONGENITAL HEART DISEASE
1.Unrepaired Cyanotic Heart Disease including
palliative shunt/conduits
2.Compltely repaired CHD with prosthetic material
3.Repaired CHD with residual defects
4.Cardiac transplantation receipients
CURRENT RECOMMENDATIONS FOR
ANTICOAGULATION AND CENTRAL NEUROXIAL
BLOCK
RECOMMENDATIONS LABORATORY
ABCIXIMAB/EPTIFI
AVOID NEUROXIAL
BATIDE/TIROFIBA
BLOC
N
STOP 4-5 DAYS PRIOR
PT/INR BEFORE
MONITOR FOR 24
AND AFTER
HRS AFTER
ANTICOAGULATNS WARFARIN NEUROXIAL
REMOVAL OF
BLOCK
EPIDURAL
INR TO BE <1.5
CATHETER
RECOMMENDATIONS LABORATORY
>4 DAYS –
IF ON SUB CUT
HEPARIN DELAY UNTIL BLOCK CHECK
HEPARIN
PLATELETES
DELAY UNTIL 1 HR
AFTER BLOCK
IV HEPARIN REMOVE CATHETER DO PTT
AFTER 2-4 HRS OF
LAST DOSE
PRE OP – BLOCK
AFTER 12 HRS OF
LAST DOSE (DELAY 24
HRS IF HIGH DOSE
LMWH THE PT GIVEN)
REMOVE 12 HRS
AFTER LAST DOSE
AND WAIT 2 HRS TILL
NEXT DOSE
TO CONCLUDE
• MILLER 7 TH EDITION
• OXFORD HAND BOOK
• RASHID KHAN –AIRWAY MANAGEMENT
THANK YOU